New study to check if antivirals help high-risk COVID patients
NCT ID NCT06683937
First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 23 times
Summary
This study reviews medical records of 300 immunocompromised adults hospitalized with COVID-19 in France. Researchers want to see how patients recover after treatment with antiviral drugs like remdesivir or nirmatrelvir/ritonavir. The goal is to understand if these treatments help and what side effects occur, since these patients are at higher risk for severe illness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOCOMPROMISED PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH Périgueux
Périgueux, 24000, France
Contact Email: •••••@•••••
-
CHD Vendée (La Roche sur Yon)
La Roche-sur-Yon, 85000, France
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
CHRU Lille
Lille, 59000, France
Contact Email: •••••@•••••
-
CHU Angers
Angers, 49000, France
Contact Email: •••••@•••••
-
CHU Caen
Caen, 14000, France
Contact Email: •••••@•••••
-
CHU Nantes
Nantes, 44000, France
Contact Email: •••••@•••••
-
CHU Nord Marseille
Marseille, 13000, France
Contact Email: •••••@•••••
-
CHU Nîmes Caremeau
Nîmes, 30000, France
Contact Email: •••••@•••••
-
CHU Poitiers
Poitiers, 86000, France
Contact Email: •••••@•••••
-
CHU Reims
Reims, 51100, France
Contact Email: •••••@•••••
-
CHU Sud Réunion
Saint-Pierre, 97410, France
Contact Email: •••••@•••••
-
CHU Toulouse
Toulouse, 31000, France
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Hôpital Bichat
Paris, 75018, France
Contact Email: •••••@•••••
-
Hôpital Necker-Enfants Malades
Paris, 75015, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Pasteur, Colmar
Colmar, 68000, France
Contact Email: •••••@•••••
-
Hôpital Saint-Louis
Paris, 75010, France
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.